Nordic RWD conference, meet us there
ESiOR Ltd takes part in Nordic conference on Real World Data – Collaboration between pharma industry and Academia on November 29-30, 2016, in Helsinki. We
Creating Insights
ESiOR Ltd takes part in Nordic conference on Real World Data – Collaboration between pharma industry and Academia on November 29-30, 2016, in Helsinki. We
A large proportion of patients with atrial fibrillation (AF) do not attain the treatment targets with traditional warfarin treatment. As a result, they remain at
Many patients with major depressive disorder (MDD) do not have adequate response to the first medical treatment or have adverse effects that lead to treatment
It is time for celebration. ESiOR will participate in International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress in Vienna for the tenth
Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients. SpringerPlus 2016;5:1354. Julkaisuluettelo
ESiOR participated in Terveys ja talous -päivät (Finnish seminar on health and economics) and presented a new study on cost-effectiveness of atrial fibrillation treatments “Eteisvärinän
ESiOR Oy participates in the 4th Nordic Conference on Research in Patient Safety and Quality in Healthcare 19th-20th May 2016 in Hotel Puijonsarvi, Kuopio. We will be
Most health economists have probably faced a situation where ICER, CEEF, CEAF, EVPI or some other complicated cost-utility analysis outcome do not alone make the
ESiOR had the privilege to participate in the excellent working group meeting “Management, steering and surveillance by knowledge” organised by the Finnish Ministry of Social
ESiOR participated actively in Utilization of SOTE (social welfare and health care) information seminar , which took place 27th January 2016 in Helsinki, Finland. CEO Erkki Soini
The publication promotes some of the key expertise and opportunities that Kuopio offers for developing companies as well as presents the local health and wellbeing
Single-bed hospital rooms are associated with significant benefits based on earlier research. However, the initial investment per bed in single-bed rooms exceeds the initial investment